@GeriMedJC excited to hear from Dr. Jenny Huang @JennyYQHuang about supportive shoes for osteoarthritis and Dr. Alex Day about delirium prevention with dexmedetomidine at tomorrow’s JC
Next #GeriMedJC on Feb 26 at 08:00 ET we discuss @AnnalsofIM study on the Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults https://t.co/ib9wcf1dh9
Tune into #GeriMedJC on Nov 27 at 08:00 AM ET via Zoom: https://t.co/10EKfkm5Cg Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation. https://t.co/GBeehYPZAq
Exciting special #COLLAB edition of #GeriMedJC on Oct 16 at 08:00 with @UofTGSx. Thiamine for Prevention of Postoperative Delirium in Patients
Undergoing Gastrointestinal Surgery: A Randomized Clinical Trial https://t.co/TmjKsKDZru
Want to know if you can safely de-prescribe antihypertensive medications in older adults?
Link to the OPTIMISE trial from @JAMA_current#GeriMedJC
https://t.co/1iAwSdrIzY @Deprescribing
Live on #GeriMedJC right now! https://t.co/10EKfkm5Cg The OPTIMISE trial: Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older
I’ve added to my #Geriatric#CGA Social History section:
“Virtual Connectivity” to #WhatsApp, #FaceTime, #Zoom and who, if need be, can facilitate it.
FYI 1/3 adults age 65+ unconnected to virtual modes.
Recommend all in healthcare ask their patients. @drgigiosler@CanGeriSoc
#GeriMedJC returns for the 2020/21 academic year! Join us July 31 at 08:00ET on Zoom: https://t.co/10EKfkm5Cg
Reducing Unnecessary Sedative-hypnotic use among Hospitalised Older Adults, Study from @SinaiHealth by @ChristineSoong
For-profit versus not-for-profit: how does the ownership of care homes impact the risk for #COVID19 outbreaks and deaths in longterm care? @NathanStall and @Andrew_P_Costa discuss new evidence from Ontario: https://t.co/Ge8UTaW23t #CMAJpodcast#cdnhealth
Our new @ICESOntario study in @AnnalsofIM reporting dramatic increases in synthetic cannabinoid prescriptions for older adults: https://t.co/XPJQ5CVaSf
Most use was off-label and among older adults with multimorbidity and polypharmacy. Led by star geriatrics fellow Dena Sommer.